Surgery for spontaneous intracerebral hemorrhage

Airton Leonardo de Oliveira Manoel, Airton Leonardo de Oliveira Manoel

Abstract

Spontaneous intracerebral hemorrhage is a devastating disease, accounting for 10 to 15% of all types of stroke; however, it is associated with disproportionally higher rates of mortality and disability. Despite significant progress in the acute management of these patients, the ideal surgical management is still to be determined. Surgical hematoma drainage has many theoretical benefits, such as the prevention of mass effect and cerebral herniation, reduction in intracranial pressure, and the decrease of excitotoxicity and neurotoxicity of blood products.Several surgical techniques have been considered, such as open craniotomy, decompressive craniectomy, neuroendoscopy, and minimally invasive catheter evacuation followed by thrombolysis. Open craniotomy is the most studied approach in this clinical scenario, the first randomized controlled trial dating from the early 1960s. Since then, a large number of studies have been published, which included two large, well-designed, well-powered, multicenter, multinational, randomized clinical trials. These studies, The International Surgical Trial in Intracerebral Hemorrhage (STICH), and the STICH II have shown no clinical benefit for early surgical evacuation of intraparenchymal hematoma in patients with spontaneous supratentorial hemorrhage when compared with best medical management plus delayed surgery if necessary. However, the results of STICH trials may not be generalizable, because of the high rates of patients' crossover from medical management to the surgical group. Without these high crossover percentages, the rates of unfavorable outcome and death with conservative management would have been higher. Additionally, comatose patients and patients at risk of cerebral herniation were not included. In these cases, surgery may be lifesaving, which prevented those patients of being enrolled in such trials. This article reviews the clinical evidence of surgical hematoma evacuation, and its role to decrease mortality and improve long-term functional outcome after spontaneous intracerebral hemorrhage.

Keywords: Glasgow outcome scale; Hypertensive intracerebral hemorrhage; Intracerebral hemorrhage; MISTIE; Neurosurgical procedures; STICH; Stroke.

Conflict of interest statement

The author declares that he has no competing interests.

Figures

Fig. 1
Fig. 1
Mechanisms of secondary brain injury after ICH. MLS - midline shift; IVH - intraventricular hemorrhage
Fig. 2
Fig. 2
Case 01 of open craniotomy for hematoma drainage. a Day 1—a large intraparenchymal hematoma centered on the putamen, right insular, and frontotemporal region, with extravasation into the subarachnoid space of the sylvian fissure and temporal fossa, measuring about 6.1 × 4.5 × 4.8 cm on its largest axes. b Day 2—Hematoma was surgically removed by open craniotomy. CT shows signs of surgical manipulation characterized by enlargement and densification of soft tissue planes with gaseous foci underlying the right parietotemporal craniotomy. There was reduction of the dimensions of the intraparenchymal hematoma. c Day 7—Follow-up CT scan 6 days after surgical drainage. d Day 21—Follow-up CT scan 21 days after surgical drainage. Patient was discharged home after this last CT scan with a modified Rankin scale 4 (able to walk with assistance)
Fig. 3
Fig. 3
Case 02 of open craniotomy for hematoma drainage. a, b Day 1Large hematoma in the left cerebral hemisphere leading to collapse of the left lateral ventricle with a midline shift of 12 mm, with a large left ventricular and third ventricle flooding, as well as diffuse effacement of cortical sulci of that hemisphere. ce Day 2—Left frontoparietal craniotomy, with well-positioned bone fragment, aligned and fixed with metal clips. Reduction of the left frontal/frontotemporal intraparenchymal hematic content, with remnant hematic residues and air foci in this region. There was a significant reduction in the mass effect, with a decrease in lateral ventricular compression and a reduction in the midline shift. Bifrontal pneumocephalus causing shift and compressing the adjacent parenchyma. fh Day 36—Resolution of residual hematic residues and pneumocephalus. Encephalomalacia in the left frontal/frontotemporal region. Despite the good surgical results, the patient remained in vegetative state
Fig. 4
Fig. 4
Open craniotomy. Patient lies on an operating table and receives general anesthesia. The head is set in a three-pin skull fixation device attached to the operating table, in order to hold the head standing still. Once the anesthesia and positioning are established, skin is prepared, cleaned with an antiseptic solution, and incised typically behind the hairline. Then, both skin and muscles are dissected and lifted off the skull. Once the bone is exposed, burr holes are built in by a special drill. The burr holes are made to permit the entrance of the craniotome. The craniotomy flap is lifted and removed, uncovering the dura mater. The bone flap is stored to be replaced at the end of the procedure. The dura mater is then opened to expose the brain parenchyma. Surgical retractors are used to open a passage to assess the hematoma. After the hematoma is drained, the retractors are removed, the dura mater is closed, and the bone flap is positioned, aligned, and fixed with metal clips. Finally, the skin is sutured
Fig. 5
Fig. 5
Surgical trajectories of catheter insertion in minimally invasive surgery. This figure was adapted from previously published images by Fam et al. [49]. a Basal ganglia hemorrhage (caudate, putamen, or anterior capsule). The catheter is inserted through the forehead. Catheter trajectory: along the clot longitudinal axis. b Thalamic or posterior capsular hemorrhage. The catheter is inserted through the parietal-occipital area. Catheter trajectory: along the clot longitudinal axis. c Lobar hemorrhage. The catheter is inserted through the superficial area contiguous to the clot. Catheter trajectory: along the clot widest axis

References

    1. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–176. doi: 10.1016/S1474-4422(09)70340-0.
    1. Ariesen MJ, Claus SP, Rinkel GJE, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34:2060–2065. doi: 10.1161/01.STR.0000080678.09344.8D.
    1. Yamada M. Cerebral amyloid angiopathy: emerging concepts. J Stroke. 2015;17:17–30. doi: 10.5853/jos.2015.17.1.17.
    1. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–2365. doi: 10.1056/NEJMoa1214609.
    1. Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375:1033–1043. doi: 10.1056/NEJMoa1603460.
    1. Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, Christensen H, et al. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;391:2107–2115. doi: 10.1016/S0140-6736(18)31033-X.
    1. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–2137. doi: 10.1056/NEJMoa0707534.
    1. Wong JM, Ziewacz JE, Ho AL, Panchmatia JR, Kim AH, Bader AM, et al. Patterns in neurosurgical adverse events: open cerebrovascular neurosurgery. Neurosurg Focus. 2012;33:E15. doi: 10.3171/2012.7.FOCUS12181.
    1. Hemphill JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–2060. doi: 10.1161/STR.0000000000000069.
    1. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. The Lancet Neurol. 2006;5:53–63. doi: 10.1016/S1474-4422(05)70283-0.
    1. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27:1783–1787. doi: 10.1161/01.STR.27.10.1783.
    1. Dowlatshahi D, Demchuk AM, Flaherty ML, Ali M, Lyden PL, Smith EE. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76:1238–1244. doi: 10.1212/WNL.0b013e3182143317.
    1. Moullaali TJ, Wang X, Martin RH, Shipes VB, Robinson TG, Chalmers J, et al. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol. 2019;18:857–864. doi: 10.1016/S1474-4422(19)30196-6.
    1. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5. doi: 10.1161/01.STR.28.1.1.
    1. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–993. doi: 10.1161/01.STR.24.7.987.
    1. Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC, Tuhrim S. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage editorial comment: a simple, reliable grading scale for Intracerebral hemorrhage. Stroke. 2001;32:891–897. doi: 10.1161/01.STR.32.4.891.
    1. Witsch J, Neugebauer H, Zweckberger K, Jüttler E. Primary cerebellar haemorrhage: complications, treatment and outcome. Clin Neurol Neurosurg. 2013;115:863–869. doi: 10.1016/j.clineuro.2013.04.009.
    1. de Oliveira Manoel AL, Goffi A, Zampieri FG, Turkel-Parrella D, Duggal A, Marotta TR, et al. The critical care management of spontaneous intracranial hemorrhage: a contemporary review. Crit Care. 2016;20:1–29.
    1. Gong C, Boulis N, Qian J, Turner DE, Hoff JT, Keep RF. Intracerebral hemorrhage-induced neuronal death. Neurosurgery. 2001;48:875–882.
    1. Qureshi AI, Ling GS, Khan J, Suri MF, Miskolczi L, Guterman LR, et al. Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage. Crit Care Med. 2001;29:152–157. doi: 10.1097/00003246-200101000-00030.
    1. Flaherty ML, Beck J. Surgery for intracerebral hemorrhage: moving forward or making circles? Stroke. 2013;44:2953–2954. doi: 10.1161/STROKEAHA.113.002533.
    1. Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin-Schild S, Khaja AM, et al. Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology. 2008;70:848–852. doi: 10.1212/01.wnl.0000304930.47751.75.
    1. Hemphill JC, Lam A. Emergency neurological life support: Intracerebral hemorrhage. Neurocrit Care. 2017;27:89–101. doi: 10.1007/s12028-017-0453-0.
    1. Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017;389:603–611. doi: 10.1016/S0140-6736(16)32410-2.
    1. Wang D, Liu J, Norton C, Liu M, Selim M. Local fibrinolytic therapy for intraventricular hemorrhage: a meta-analysis of randomized controlled trials. World Neurosurg. 2017;107:1016–1024. doi: 10.1016/j.wneu.2017.07.135.
    1. Hinson HE, Melnychuk E, Muschelli J, Hanley DF, Awad IA, Ziai WC. Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care. 2012;16:399–405. doi: 10.1007/s12028-011-9569-9.
    1. Staykov D, Kuramatsu JB, Bardutzky J, Volbers B, Gerner ST, Kloska SP, et al. Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: a randomized trial and individual patient data meta-analysis. Ann Neurol. 2017;81:93–103. doi: 10.1002/ana.24834.
    1. Li Y, Zhang H, Wang X, She L, Yan Z, Zhang N, et al. Neuroendoscopic surgery versus external ventricular drainage alone or with intraventricular fibrinolysis for intraventricular hemorrhage secondary to spontaneous supratentorial hemorrhage: a systematic review and meta-analysis. PLoS One. 2013;8:e80599. doi: 10.1371/journal.pone.0080599.
    1. Sacco S, Marini C, Toni D, Olivieri L, Carolei A. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke. 2009;40:394–399. doi: 10.1161/STROKEAHA.108.523209.
    1. Babi M-A, James ML. Spontaneous intracerebral hemorrhage: should we operate? Front Neurol. 2017;8:394. doi: 10.3389/fneur.2017.00394.
    1. Mckissock W, Richardson A, Taylor J. Primary intracerebral haemorrhage. Lancet. 1961;278:221–226. doi: 10.1016/S0140-6736(61)90353-1.
    1. Auer LM, Deinsberger W, Niederkorn K, Gell G, Kleinert R, Schneider G, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg. 1989;70:530–535. doi: 10.3171/jns.1989.70.4.0530.
    1. Juvela S, Heiskanen O, Poranen A, Valtonen S, Kuurne T, Kaste M, et al. The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg. 1989;70:755–758. doi: 10.3171/jns.1989.70.5.0755.
    1. Batjer HH, Reisch JS, Allen BC, Plaizier LJ, Su CJ. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage. A prospective randomized trial. Arch Neurol. 1990;47:1103–1106. doi: 10.1001/archneur.1990.00530100071015.
    1. Morgenstern LB, Frankowski RF, Shedden P, Pasteur W, Grotta JC. Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. Neurology. 1998;51:1359–1363. doi: 10.1212/WNL.51.5.1359.
    1. Zuccarello M, Brott T, Derex L, Kothari R, Sauerbeck L, Tew J, et al. Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke. 1999;30:1833–1839. doi: 10.1161/01.STR.30.9.1833.
    1. Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology. 2001;56:1294–1299. doi: 10.1212/WNL.56.10.1294.
    1. Teernstra OPM, Evers SMAA, Lodder J, Leffers P, Franke CL, Blaauw G, et al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA) Stroke. 2003;34:968–974. doi: 10.1161/01.STR.0000063367.52044.40.
    1. Hattori N, Katayama Y, Maya Y, Gatherer A. Impact of stereotactic hematoma evacuation on activities of daily living during the chronic period following spontaneous putaminal hemorrhage: a randomized study. J Neurosurg. 2004;101:417–420. doi: 10.3171/jns.2004.101.3.0417.
    1. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–397. doi: 10.1016/S0140-6736(05)70233-6.
    1. Pantazis G, Tsitsopoulos P, Mihas C, Katsiva V, Stavrianos V, Zymaris S. Early surgical treatment vs conservative management for spontaneous supratentorial intracerebral hematomas: A prospective randomized study. Surg Neurol. 2006;66:492–501. doi: 10.1016/j.surneu.2006.05.054.
    1. Kim YZ, Kim KH. Even in patients with a small hemorrhagic volume, stereotactic-guided evacuation of spontaneous intracerebral hemorrhage improves functional outcome. J Korean Neurosurg Soc. 2009;46:109–115. doi: 10.3340/jkns.2009.46.2.109.
    1. Wang W-Z, Jiang B, Liu H-M, Li D, Lu C-Z, Zhao Y-D, et al. Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage: results from a randomized clinical trial in China. Int J Stroke. 2009;4:11–16. doi: 10.1111/j.1747-4949.2009.00239.x.
    1. Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382:397–408. doi: 10.1016/S0140-6736(13)60986-1.
    1. Hanley DF, Thompson RE, Muschelli J, Rosenblum M, McBee N, Lane K, et al. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016;15:1228–1237. doi: 10.1016/S1474-4422(16)30234-4.
    1. Vespa P, Hanley D, Betz J, Hoffer A, Engh J, Carter R, et al. ICES (intraoperative stereotactic computed tomography-guided endoscopic surgery) for brain hemorrhage: a multicenter randomized controlled trial. Stroke. 2016;47:2749–2755. doi: 10.1161/STROKEAHA.116.013837.
    1. Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;393:1021–1032. doi: 10.1016/S0140-6736(19)30195-3.
    1. Tan SH, Ng PY, Yeo TT, Wong SH, Ong PL, Venketasubramanian N. Hypertensive basal ganglia hemorrhage: a prospective study comparing surgical and nonsurgical management. Surg Neurol. 2001;56:287–292. doi: 10.1016/S0090-3019(01)00561-4.
    1. Fam MD, Hanley D, Stadnik A, Zeineddine HA, Girard R, Jesselson M, et al. Surgical performance in minimally invasive surgery plus recombinant tissue plasminogen activator for intracerebral hemorrhage evacuation phase III clinical trial. Neurosurgery. 2017;81:860–866.
    1. Awad IA, Polster SP, Carrion-Penagos J, Thompson RE, Cao Y, Stadnik A, et al. Surgical performance determines functional outcome benefit in the minimally invasive surgery plus recombinant tissue plasminogen activator for Intracerebral hemorrhage evacuation (MISTIE) procedure. Neurosurgery. 2019;84:1157–1168. doi: 10.1093/neuros/nyz077.
    1. Mould WA, Carhuapoma JR, Muschelli J, Lane K, Morgan TC, McBee NA, et al. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013;44:627–634. doi: 10.1161/STROKEAHA.111.000411.
    1. Kellner CP, Chartrain AG, Nistal DA, Scaggiante J, Hom D, Ghatan S, et al. The stereotactic intracerebral hemorrhage underwater blood aspiration (SCUBA) technique for minimally invasive endoscopic intracerebral hemorrhage evacuation. J Neurointerv Surg. 2018;10:771–776. doi: 10.1136/neurintsurg-2017-013719.
    1. Scaggiante J, Zhang X, Mocco J, Kellner CP. Minimally invasive surgery for Intracerebral hemorrhage. Stroke. 2018;49:2612–2620. doi: 10.1161/STROKEAHA.118.020688.
    1. Steiner T, Salman RA-S, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European stroke organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9:840–855. doi: 10.1111/ijs.12309.
    1. Jauch Edward C., Pineda Jose A., Claude Hemphill J. Emergency Neurological Life Support: Intracerebral Hemorrhage. Neurocritical Care. 2015;23(S2):83–93. doi: 10.1007/s12028-015-0167-0.
    1. Suarez JI, Zaidat OO, Suri MF, Feen ES, Lynch G, Hickman J, et al. Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med. 2004;32:2311–2317. doi: 10.1097/01.CCM.0000146132.29042.4C.
    1. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29:635–640. doi: 10.1097/00003246-200103000-00031.
    1. Kramer AH, Zygun DA. Do Neurocritical care units save lives? Measuring the impact of specialized ICUs. Neurocrit Care. 2011;14:329–333. doi: 10.1007/s12028-011-9530-y.
    1. Fletcher JJ, Kotagal V, Mammoser A, Peterson M, Morgenstern LB, Burke JF. Cost-effectiveness of transfers to centers with neurological intensive care units after intracerebral hemorrhage. Stroke. 2015;46:58–64. doi: 10.1161/STROKEAHA.114.006653.
    1. Sembill JA, Gerner ST, Volbers B, Bobinger T, Lucking H, Kloska SP, et al. Severity assessment in maximally treated ICH patients. Neurology. 2017;89:423–431. doi: 10.1212/WNL.0000000000004174.
    1. Rabinstein AA, Wijdicks EFM. Surgery for intracerebral hematoma: the search for the elusive right candidate. Rev Neurol Dis. 2006;3:163–172.
    1. Kirkman MA, Greenwood N, Singh N, Tyrrell PJ, King AT, Patel HC. Difficulties with recruiting into neurosurgical clinical trials: the surgical trial in IntraCerebral Haemorrhage II as an example. Br J Neurosurg. 2011;25:231–234. doi: 10.3109/02688697.2010.539718.
    1. Kuramatsu JB, Sembill JA, Huttner HB. Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage. Crit Care. 2019;23:1–9. doi: 10.1186/s13054-019-2492-8.
    1. Frontera JA, Lewin JJ, III, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage. Neurocrit Care. 2015;24:6–46. doi: 10.1007/s12028-015-0222-x.
    1. Nyquist P, Bautista C, Jichici D, Burns J, Chhangani S, DeFilippis M, et al. Prophylaxis of venous thrombosis in neurocritical care patients: an evidence-based guideline: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care. 2016;24:47–60. doi: 10.1007/s12028-015-0221-y.
    1. Kuramatsu JB, Gerner ST, Schellinger PD, Glahn J, Endres M, Sobesky J, et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA. 2015;313:824–836. doi: 10.1001/jama.2015.0846.
    1. Fung C, Murek M, Z'Graggen WJ, Krähenbühl AK, Gautschi OP, Schucht P, et al. Decompressive hemicraniectomy in patients with supratentorial intracerebral hemorrhage. Stroke. 2012;43:3207–3211. doi: 10.1161/STROKEAHA.112.666537.
    1. Heuts SG, Bruce SS, Zacharia BE, Hickman ZL, Kellner CP, Sussman ES, et al. Decompressive hemicraniectomy without clot evacuation in dominant-sided intracerebral hemorrhage with ICP crisis. Neurosurg Focus. 2013;34:E4. doi: 10.3171/2013.2.FOCUS1326.
    1. Hayes SB, Benveniste RJ, Morcos JJ, Aziz-Sultan MA, Elhammady MS. Retrospective comparison of craniotomy and decompressive craniectomy for surgical evacuation of nontraumatic, supratentorial intracerebral hemorrhage. Neurosurg Focus. 2013;34:E3. doi: 10.3171/2013.2.FOCUS12422.
    1. Kirollos RW, Tyagi AK, Ross SA, van Hille PT, Marks PV. Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery. 2001;49:1378–1377. doi: 10.1097/00006123-200112000-00015.
    1. Mathew P, Teasdale G, Bannan A, Oluoch-Olunya D. Neurosurgical management of cerebellar haematoma and infarct. J Neurol Neurosurg Psychiatry. 1995;59:287–292. doi: 10.1136/jnnp.59.3.287.
    1. Kobayashi S, Sato A, Kageyama Y, Nakamura H, Watanabe Y, Yamaura A. Treatment of hypertensive cerebellar hemorrhage: surgical or conservative management? Neurosurgery. 1994;34:246–250. doi: 10.1227/00006123-199402000-00006.
    1. Da Pian R, Bazzan A, Pasqualin A. Surgical versus medical treatment of spontaneous posterior fossa haematomas: a cooperative study on 205 cases. Neurol Res. 1984;6:145–151. doi: 10.1080/01616412.1984.11739680.
    1. Kuramatsu JB, Biffi A, Gerner ST, Sembill JA, Sprügel MI, Leasure A, et al. Association of Surgical Hematoma Evacuation vs conservative treatment with functional outcome in patients with cerebellar Intracerebral hemorrhage. JAMA. 2019;322:1392–1403. doi: 10.1001/jama.2019.13014.

Source: PubMed

3
Abonneren